Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioNTech SE

www.biontech.de

Latest From BioNTech SE

Pfizer Chief Calls Patent Pool ‘Nonsense’, Fears Tussle Over Vaccine

Pharma will oppose a patent pool, but the world still needs a way to guarantee fair access to COVID-19 vaccines.

Commercial Companies

China Still Leading Vaccines Race Despite Moderna Data, US 'Warp Speed' Plan?

The unveiling of US president Donald Trump’s 'Warp Speed’ plan to fast-track a coronavirus vaccine and the latest promising Phase I data from Moderna's candidate haven't seemed to swing China’s belief that it’s still leading the race.

Coronavirus COVID-19 China

Can GSK Veteran Moncef Slaoui Get COVID-19 Vaccine Development To Warp Speed?

President Trump's Operation Warp Speed initiative aims to have a COVID-19 vaccine available by the end of the year; Slaoui, who helped get the first cervical cancer vaccine to market and win European approval of the first malaria vaccine while at GlaxoSmithKline, is tasked with coordinating the government's contributions to coronavirus vaccine effort and achieving what would be twin scientific and manufacturing miracles. 

Coronavirus COVID-19 Vaccines

Pharma Leaders Confront Another Daunting Challenge: Meeting COVID-19 Demand

Pharma leaders at the CNBC Healthy Returns virtual conference said they are optimistic industry will deliver a SARS-COV-2 vaccine, but ramping up the supply will require time and collaboration.

Vaccines Coronavirus COVID-19
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Drug Discovery Tools
      • Bioinformatics
    • Gene Therapy, Cell Therapy
    • Large Molecule
      • Antibodies
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • BioNTech SE
  • Senior Management
  • Ugur Sahin, MD, CEO
    Sierk Poetting, PhD, CFO & COO
    Sean Marett, CBO & Chief Commercial Officer
    Özlem Türeci , MD, CMO
    Ryan Richardson, Chief Strategy Officer
  • Contact Info
  • BioNTech SE
    Phone: 6131 9084 0
    An der Goldgrube 12
    Mainz, D-55131
    Germany
UsernamePublicRestriction

Register